Author

Eisuke Suzuki

Institution: Meiji Seika Pharma Co., Ltd. (Japan)

Observed institution: Meiji Seika Pharma Co., Ltd. (Japan)

OpenAlex ID: A5158770534

In vitro activity of aztreonam–nacubactam and cefepime–nacubactam against a global collection of clinically important Gram-negative Bacilli collected in 2021–2023

2026 · James A Karlowsky, Mark Estabrook, et al. · JAC-Antimicrobial Resistance · 3

In vitro activities of aztreonam/nacubactam and cefepime/nacubactam against a global collection of molecularly characterized Enterobacterales isolates carrying carbapenemases: a global antimicrobial resistance surveillance study from 2021 to 2023

2026 · Mark Estabrook, Eisuke Suzuki, et al. · JAC-Antimicrobial Resistance

Works count: 2

Citation count: 3

H-index: 1

I10-index: